Exercising harder -- and shorter -- can help Type 2 diabetes

December 12, 2011

Bethesda, Md. (Dec. 12, 2011)--Regular exercise has proven benefits in preventing and treating type 2 diabetes, but many patients find it tough to meet the American Diabetes Association guidelines of 150 minutes of moderate to vigorous exercise a week. A new study, conducted by researchers at McMaster University, suggests that there could be a better way. In a small proof-of-principle study in eight type 2 diabetes patients, the researchers found that exercising at a very high intensity, but for a mere 30 minutes a week within a 75 minute total time commitment, lowered overall blood sugar concentrations, reduced post-meal blood sugar spikes, and increased skeletal mitochondrial capacity, a marker of metabolic health. The findings suggest that exercising harder, but in a significantly shorter amount of time, could provide benefits similar to longer, but more moderate, activity.

The article is entitled "Low-Volume High-Intensity Interval Training Reduces Hyperglycemia and Increases Muscle Mitochondrial Capacity in Patients with Type 2 Diabetes." It appears in the current edition of the Journal of Applied Physiology, published by the American Physiological Society.

Methodology

Working with eight type 2 diabetic volunteers recruited through local diabetes clinics, information sessions, and advertising, the researchers gave each individual a baseline exam to test blood sugar over a 24-hour period, assess fitness levels, and take biopsies of thigh muscle to measure muscle mitochondrial protein levels. For the next two weeks, the researchers showed up for a total of six supervised training sessions. Each session involved pedaling on a stationary bike for 10 repetitions of 60 seconds apiece at about 90 percent of maximal heart rate, interspersed with 60 seconds of rest, capped by a short warm-up and cool-down. Each entire exercise session lasted 25 minutes of which only 10 minutes was spent performing vigorous intensity exercise. After the two-week training period, the researchers reassessed each volunteer's blood sugar and fitness levels and took a second muscle biopsy.

Results

The results showed significant improvement in several measures of diabetic health. All the volunteers had lower 24-hour average blood sugar concentrations, and blood sugar spikes after breakfast, lunch, and dinner were significantly reduced. The muscle biopsies revealed higher amounts of mitochondrial proteins, suggesting that the high-intensity, low-volume training increased the numbers of muscle cell power generators, a marker of improved metabolic health. Although the training regimen didn't decrease body mass in any of the participants, it did increase the maximal workload that each was able to achieve on the stationary bike and decreased heart rate during exercise, markers of improved fitness.

Importance of the Findings

These findings suggest that exercising at a very high exertion level, but for a decreased amount of time, could have significant benefits for diabetic patients that rival those of traditional, but lengthy, periods of moderate exercise. Participants did not lose weight during the study, but the increase in mitochondrial proteins suggests that the training regimen changed their body compositions. The authors suggest that body composition change could be responsible for the effects observed in this study, but future research will be necessary to identify the true mechanism behind these results.

"Given that the majority of individuals with and without type 2 diabetes do not accumulate sufficient exercise to achieve health benefits, and the most common cited barrier to regular exercise is a lack of time, our results suggest that low-volume high-intensity training may be a viable, time-efficient strategy to improve health in patients with type 2 diabetes," the authors say.

Study Team

The study was conducted by Jonathan P. Little and his colleagues, Jenna B. Gillen, Michael E. Percival, Adeel Safdar, Mark A. Tarnopolsky, Zubin Punthakee, and Martin J. Gibala, all of McMaster University, and Mary E. Jung of the University of British Columbia Okanagan.
-end-
NOTE TO EDITORS: The abstract is available at http://bit.ly/vCWJCa. The study is online at http://bit.ly/szq4Sm. To request an interview with a member of the research team please contact Donna Krupa at dkrupa@the-aps.org, @Phyziochick, or 301.634.7209.

Physiology is the study of how molecules, cells, tissues and organs function to create health or disease. The American Physiological Society (APS; www.the-APS.org/press) has been an integral part of the discovery process since it was established in 1887. To keep up with the science, follow @Phyziochick on Twitter.

American Physiological Society

Related Diabetes Articles from Brightsurf:

New diabetes medication reduced heart event risk in those with diabetes and kidney disease
Sotagliflozin - a type of medication known as an SGLT2 inhibitor primarily prescribed for Type 2 diabetes - reduces the risk of adverse cardiovascular events for patients with diabetes and kidney disease.

Diabetes drug boosts survival in patients with type 2 diabetes and COVID-19 pneumonia
Sitagliptin, a drug to lower blood sugar in type 2 diabetes, also improves survival in diabetic patients hospitalized with COVID-19, suggests a multicenter observational study in Italy.

Making sense of diabetes
Throughout her 38-year nursing career, Laurel Despins has progressed from a bedside nurse to a clinical nurse specialist and has worked in medical, surgical and cardiac intensive care units.

Helping teens with type 1 diabetes improve diabetes control with MyDiaText
Adolescence is a difficult period of development, made more complex for those with Type 1 diabetes mellitus (T1DM).

Diabetes-in-a-dish model uncovers new insights into the cause of type 2 diabetes
Researchers have developed a novel 'disease-in-a-dish' model to study the basic molecular factors that lead to the development of type 2 diabetes, uncovering the potential existence of major signaling defects both inside and outside of the classical insulin signaling cascade, and providing new perspectives on the mechanisms behind insulin resistance in type 2 diabetes and possibly opportunities for the development of novel therapeutics for the disease.

Tele-diabetes to manage new-onset diabetes during COVID-19 pandemic
Two new case studies highlight the use of tele-diabetes to manage new-onset type 1 diabetes in an adult and an infant during the COVID-19 pandemic.

Genetic profile may predict type 2 diabetes risk among women with gestational diabetes
Women who go on to develop type 2 diabetes after having gestational, or pregnancy-related, diabetes are more likely to have particular genetic profiles, suggests an analysis by researchers at the National Institutes of Health and other institutions.

Maternal gestational diabetes linked to diabetes in children
Children and youth of mothers who had gestational diabetes during pregnancy are at increased risk of diabetes themselves, according to new research published in CMAJ (Canadian Medical Association Journal).

Two diabetes medications don't slow progression of type 2 diabetes in youth
In youth with impaired glucose tolerance or recent-onset type 2 diabetes, neither initial treatment with long-acting insulin followed by the drug metformin, nor metformin alone preserved the body's ability to make insulin, according to results published online June 25 in Diabetes Care.

People with diabetes visit the dentist less frequently despite link between diabetes, oral health
Adults with diabetes are less likely to visit the dentist than people with prediabetes or without diabetes, finds a new study led by researchers at NYU Rory Meyers College of Nursing and East Carolina University's Brody School of Medicine.

Read More: Diabetes News and Diabetes Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.